High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa

INTRODUCTION: Treatment success rates of rifampicin resistant (RR)/multi-drug resistant (MDR) tuberculosis (TB) in South Africa range from 43–48%, falling short of the World Health Organization’s target of ≥75%. We present rates and assess predictors of attrition by 12 months on treatment. METHODS:...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:PLoS One
Hoofdauteurs: Hirasen, Kamban, Berhanu, Rebecca, Evans, Denise, Rosen, Sydney, Sanne, Ian, Long, Lawrence
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Public Library of Science 2018
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6177165/
https://ncbi.nlm.nih.gov/pubmed/30300403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0205463
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items